GSA Capital Partners’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-450	Closed	-$89K	–	1789
2021 Q3	$89K	Buy	+450	New	+$89K	0.01%	1332
2021 Q1	–	Sell	-1,953	Closed	-$384K	–	1483
2020 Q4	$384K	Sell	1,953 -243	-11%	-$47.8K	0.06%	598
2020 Q3	$389K	Buy	+2,196	New	+$389K	0.06%	561